Skip to main content
. 2021 Mar 9;21:252. doi: 10.1186/s12885-021-07976-5

Fig. 2.

Fig. 2

Elevated DGAT1 expression in different types of gastric cancer indicated a worse outcome in patients. a Aberrant DGAT1 expression in different gastric cancer types (Diffuse type stomach adenocarcinoma, n = 56; Esophageal adenocarcinoma, n = 85; Esophageal squamous cell carcinoma, n = 78; Mucinous stomach adenocarcinoma, n = 19; Papillary stomach adenocarcinoma, n = 7; Signet ring cell carcinoma of the stomach, n = 13; Stomach adenocarcinoma, n = 204; Tubular stomach adenocarcinoma, n = 71). Kaplan-meier plots of gastric cancer patients based on overall survival (b), first progression (c) and post progression survival (d). Data in (a) were collected from the cBioPortal database. Data in (b-d) were collected from the Kaplan-Meier Plotter database (OS, n = 165; FP, n = 121; PPS, n = 49)